scispace - formally typeset
P

Peter G. Gibson

Researcher at University of Newcastle

Publications -  774
Citations -  53254

Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.

Papers
More filters
Book ChapterDOI

Asthma: Interrelationships with Pregnancy

TL;DR: Pregnancy affects pregnancy, and asthma affects asthma, and these interrelationships affect the health of both mother and baby and have influences over the future health of the offspring.
Journal ArticleDOI

Impact of initiatinG bioLogics In patients with severe asThma on long-Term OCS or frEquent Rescue steroids (GLITTER): data from the International Severe Asthma Registry.

TL;DR: In this paper , the authors examined the effectiveness of initiating biologics in a large, real-world cohort of adult patients with severe asthma and high oral corticosteroid exposure (HOCS), and compared to effectiveness of continuing with HOCS alone.
Journal ArticleDOI

Response to ‘25-OH Vitamin D concentrations measured by LC-MS/MS are equivalent in serum and EDTA plasma’

TL;DR: In this article , the synthesis and characterization of a dimer in which two nuclei of 3β-acetoxy-19-hydroxyandrost-5-en-17-one are linked by the fluorescent 1,4-bis(phenylethynyl)phenylene bridge attached to the oxygenated functions at positions C-19 of each steroid fragment is described.
Journal ArticleDOI

Severe asthma: implementing game‐changing science

TL;DR: Patients with severe asthma who have had positive responses to targeted monoclonal antibody therapy for asthma achieve complete symptom control and significant prednisone reduction.
Journal ArticleDOI

Sleepwalking towards more harm from asthma

TL;DR: Asthma continues to be a major but avoidable burden on the Australian health care system as mentioned in this paper and several key issues need urgent attention and action: fragmented and suboptimal care, overreliance on reliever therapies, neglect of rural and remote populations, and overprescription of oral corticosteroids.